Search Medical Condition
Please enter condition
Please choose location
 

Lung Cancer Clinical Trials

A listing of Lung Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1547) clinical trials

The main purpose of this study is to see if nivolumab on its own in combination with ipilimumab or in combination with chemotherapy is better at improving your chances of survival and at delaying the worsening of your lung cancer (called progression) when compared to standard chemotherapy treatment. This study ...

Phase

Squamous cell lung cancers make up about one-fourth of non-small cell lung cancers. Various chemotherapy drugs have been shown to improve survival for patients with advanced squamous lung cancer. Most patients will be treated at first with cisplatin or carboplatin in combination with a second chemotherapy drug such as gemcitabine, ...

Phase N/A

You are being asked to take part in this research study because you have non-small cell lung cancer, which has been removed by a surgeon. People who are not in a research study are usually offered standard treatment which may include chemotherapy and/or radiation therapy. They are then monitored after ...

Phase

The purpose of this study is to assess the safety, tolerability, and efficacy when combining INCB024360 and Nivolumab in subjects with certain cancers. This study will be conducted in 2 phases, Phase 1 (closed) and Phase 2 (open to enrollment)

Phase N/A

The primary purpose of the study is to evaluate the safety and tolerability of Epacadostat and Atezolizumab when given in combination to patients with Stage IIIB or Stage IV Non-Small Cell Lung Cancer.

Phase

This is an open label, non-randomized, multi-center study. The primary purpose of the study is to evaluate the safety, tolerability and efficacy of Epacadostat and Durvalumab when given in combination in patients with Selected Advanced Solid Tumors.

Phase N/A

People with non small cell lung cancer are asked to participate in a research study being conducted by Montefiore Medical Center

Phase N/A

MGCD265 is an orally administered receptor tyrosine kinase inhibitor that targets MET and other receptors. This study is a Phase 2 trial of MGCD265 in patients with locally advanced, unresectable or metastatic non-small cell lung cancer (NSCLC) that has activating genetic changes of the MET gene (mutation or amplification [increase ...

Phase

The objective of this study is to describe the occurrence of AEs leading to dose reduction following afatinib treatment in NSCLC patients with common EGFR mutations (Deletion 19 and/or L858R) who are 70 years of age or older.

Phase

Advanced tumors evade host immune responses by down regulation of major histocompatibility complex (MHC) molecules and tumor antigens and by creating an immune suppressive microenvironment around the tumor. Histone deacetylases (HDACs) have been implicated in the epigenetic regulation of innate and adaptive immunity. Increasing evidence supports the proposal that spectrum-selective ...

Phase N/A